Home > Quotes > PSDV

pSivida Corp. Common Stock Quote & Summary Data

Get PSDV Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading PSDV now
Exchange: NASDAQ
Industry: Capital Goods
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

pSivida Corp. Common Stock Intraday Chart

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 3.0399 $ 5.81
Low $ 2.86 $ 2.37

The current last sale of $2.87 is 21.10% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

We are a leader in the development of sustained-release drug-delivery products for treating eye diseases. Our products deliver drugs at a controlled and steady rate for months or years. We have developed three of only four sustained-release products approved by the U.S. Food and Drug Administration (FDA) for treatment of back-of-the-eye diseases. The most recent is ILUVIENĀ® for diabetic macular edema (DME), sold by our licensee in the U.S. and three European Union (EU) countries. Our lead development product, Medidur(TM) for posterior uveitis, is in pivotal phase III clinical trials. Our pre-clinical development program is focused primarily on developing products for chronic ophthalmic diseases utilizing our core technology platforms. ILUVIEN is an injectable, sustained-release micro-insert that provides treatment of DME for three years from a single administration. ILUVIEN is licensed to Alimera Sciences, Inc.  ... More ...  

Risk Grade

Where does PSDV fit in the risk graph?

Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?